Molecular constraints to interspecies transmission of viral pathogens

Nature Medicine

Volumn 10, Issue 12S, 2004, Pages S77-S81

  Webby, Richard ^a   Hoffmann, Erich ^a   Webster, Robert ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ADAPTATION; AMINO ACID COMPOSITION; BIRD; CELL TYPE; DUCK; EPIDEMIC; FOWL PLAGUE VIRUS; GENETIC REASSORTMENT; GENOME ANALYSIS; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; REVIEW; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SPECIES DIFFERENCE; SWINE; VIRUS ETIOLOGY; VIRUS MUTATION; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS TRANSMISSION; ZOONOSIS;

ANIMALS; ANTIVIRAL AGENTS; GENOME; HUMANS; MODELS, BIOLOGICAL; SPECIES SPECIFICITY; VACCINES; VIRUS DISEASES; VIRUSES; ZOONOSES;

ANAS SP.; ANIMALIA; AVES; CORONAVIRUS; FOWL PLAGUE VIRUS; GALLIFORMES; HUMAN IMMUNODEFICIENCY VIRUS; SARS CORONAVIRUS; SUS SCROFA;

EID: 10944250908     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1151     Document Type: Review

References (47)

1. Smolinski, M., Hamburg, M. & Lederberg, J. Microbial Threats to Health: Emergence, Detection, and Response. Institute of Medicine Report 2003.
2. Li, K.S. et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 430, 209–213 (2004).
3. Nie, Y. et al. Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression. Biochem. Biophys. Res. Commun. 321, 994–1000 (2004).
4. Meyer, B.J., de la Torre, J.C. & Southern, P.J. Arenaviruses: Genomic RNAs, transcription, and replication. Curr. Top. Microbiol. Immunol. 262, 139–157 (2002).
5. Holmes, K.V., Zelus, B.D., Schickli, J.H. & Weiss, S.R. Receptor specificity and receptor-induced conformational changes in mouse hepatitis virus spike glycoprotein. Adv. Exp. Med. Biol. 494, 173–181 (2001).
6. Thackray, L.B. & Holmes, K.V. Amino acid substitutions and an insertion in the spike glycoprotein extend the host range of the murine coronavirus MHV-A59. Virology 324, 510–524 (2004).
7. Guan, Y. et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302, 276–278 (2003).
8. Webster, R.G. Wet markets—a continuing source of severe acute respiratory syndrome and influenza? Lancet 363, 234–236 (2004).
9. Baranowski, E., Ruiz-Jarabo, C.M. & Domingo, E. Evolution of cell recognition by viruses. Science 292, 1102–1105 (2001).
10. Couceiro, J.N., Paulson, J.C. & Baum, L.G. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res. 29, 155–165 (1993).
11. Ito, T. et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J. Virol. 72, 7367–7373 (1998).
12. Beare, A.S. & Webster, R.G. Replication of avian influenza viruses in humans. Arch. Virol. 119, 37–42 (1991).
13. Hinshaw, V.S., Webster, R.G., Easterday, B.C. & Bean, W.J. Replication of avian influenza A viruses in mammals. Infect. Immun. 34, 354.361 (1981).
14. Hinshaw, V.S., Webster, R.G., Naeve, C.W. & Murphy, B.R. Altered tissue tropism of human-avian reassortant influenza viruses. Virology 128, 260.263 (1983).
15. Murphy, B.R. et al. Virulence of avian influenza A viruses for squirrel monkeys. Infect. Immun. 37, 1119.1126 (1982).
16. Matrosovich, M., Zhou, N., Kawaoka, Y. & Webster, R. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J. Virol. 73, 1146.1155 (1999).
17. Matrosovich, M.N., Krauss, S. & Webster, R.G. H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity. Virology 281, 156.162 (2001).
18. Matrosovich, M.N., Matrosovich, T.Y., Gray, T., Roberts, N.A. & Klenk, H.D. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl. Acad. Sci. USA 101, 4620.4624 (2004).
19. Blight, K.J., Kolykhalov, A.A. & Rice, C.M. Efficient initiation of HCV RNA replication in cell culture. Science 290, 1972.1974 (2000).
20. Isaacs, A. & Lindenmann, J. Virus interference. I. The interferon. Proc. R. Soc. Lond. B 147, 258.267 (1957).
21. Isaacs, A. & Burke, D.C. Mode of action of interferon. Nature 182, 1073.1074 (1958).
22. Katze, M.G., He, Y. & Gale, M. Jr. Viruses and interferon: A fight for supremacy. Nat. Rev. Immunol. 2, 675.687 (2002).
23. Krug, R.M., Yuan, W., Noah, D.L. & Latham, A.G. Intracellular warfare between human influenza viruses and human cells: The roles of the viral NS1 protein. Virology 309, 181.189 (2003).
24. Park, M.S. et al. Newcastle disease virus (NDV)-based assay demonstrates interferonantagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J. Virol. 77, 1501.1511 (2003).
25. Rodriguez, J.J., Parisien, J.P. & Horvath, C.M. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J. Virol. 76, 11476.11483 (2002).
26. Rodriguez, J.J., Wang, L.F. & Horvath, C.M. Hendra virus V protein inhibits interferon signaling by preventing STAT1 and STAT2 nuclear accumulation. J. Virol. 77, 11842.11845 (2003).
27. Harcourt, B.H., Sanchez, A. & Offermann, M.K. Ebola virus inhibits induction of genes by double-stranded RNA in endothelial cells. Virology 252, 179.188 (1998).
28. Enomoto, N. et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N. Engl. J. Med. 334, 77.81 (1996).
29. Garcia-Sastre, A. et al. Influenza A virus lacking the NS1 gene replicates in interferondeficient systems. Virology 252, 324.330 (1998).
30. Lu, Y., Wambach, M., Katze, M.G. & Krug, R.M. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214, 222.228 (1995).
31. Chen, Z., Li, Y. & Krug, R.M. Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3Œ-end processing machinery. EMBO J. 18, 2273.2283 (1999).
32. Nemeroff, M.E., Barabino, S.M., Li, Y., Keller, W. & Krug, R.M. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3Πend formation of cellular pre-mRNAs. Mol. Cell 1, 991.1000 (1998).
33. Parisien, J.P., Lau, J.F. & Horvath, C.M. STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication. J. Virol. 76, 6435.6441 (2002).
34. Kawaoka, Y., Krauss, S. & Webster, R.G. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J. Virol. 63, 4603.4608 (1989).
35. Scholtissek, C. & Rohde, W. von, H.V & Rott, R. On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 87, 13.20 (1978).
36. Fujii, Y., Goto, H., Watanabe, T., Yoshida, T. & Kawaoka, Y. Selective incorporation of influenza virus RNA segments into virions. Proc. Natl. Acad. Sci. USA 100, 2002.2007 (2003).
37. Webby, R.J. et al. Responsiveness to a pandemic alert: Use of reverse genetics for rapid development of influenza vaccines. Lancet 363, 1099.1103 (2004).
38. Sevilla, N., Domingo, E. & de la Torre, J.C. Contribution of LCMV towards deciphering biology of quasispecies in vivo. Curr. Top. Microbiol. Immunol. 263, 197.220 (2002).
39. Lai, M.M. Genetic recombination in RNA viruses. Curr. Top. Microbiol. Immunol. 176, 21.32 (1992).
40. Nagy, P.D. & Simon, A.E. New insights into the mechanisms of RNA recombination. Virology 235, 1.9 (1997).
41. Suarez, D.L. et al. Recombination resulting in virulence shift in avian influenza outbreak, Chile. Emerg. Infect. Dis. 10, 693.699 (2004).
42. Hahn, B.H., Shaw, G.M., De Cock, K.M. & Sharp, P.M. AIDS as a zoonosis: Scientific and public health implications. Science 287, 607.614 (2000).
43. Lemey, P. et al. Tracing the origin and history of the HIV-2 epidemic. Proc. Natl. Acad. Sci. USA 100, 6588.6592 (2003).
44. Bieniasz, P.D. Restriction factors: A defense against retroviral infection. Trends Microbiol. 11, 286.291 (2003).
45. Goff, S.P. Genetic control of retrovirus susceptibility in mammalian cells. Annu. Rev. Genet. advance online publication, 26 May 2004 (doi:10.1146/annurev. genet.38.072902.094136).
46. Kobasa, D. et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431, 703.707 (2004).
47. Tumpey, T.M. et al. Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc. Natl. Acad. Sci. USA 101, 3166.3171 (2004).